Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Superpotent drug: Assay results were slightly above specification at the time zero point.
Reason Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50…
Reason Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.
Reason Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules
Reason Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.